For example, weight reduction outcomes at 24 weeks were as follows: 1 mg : 7.2% 4 mg : 12.9% 8 mg : 17.3% 12 mg : 17.5% Placebo : 1.6% At 48 weeks, the differences became even more pronounced: 1 mg : 8.7% 4 mg : 17.1% 8 mg : 22.8% 12 mg : 24.2% Placebo : 2.1% The table below summarizes these outcomes, including the percentage of participants achieving clinically significant weight loss (5% and 15%) by dose level: Notably, doses of 8 mg and above achieved a 100% rate of clinically significant weight loss (5%) at 48 weeks, with the 12 mg dose leading to 83% of participants achieving 15% weight loss
How BPC-157 Works BPC-157 promotes rapid recovery and cellular repair by: Stimulating angiogenesis (new blood vessel formation) Enhancing collagen synthesis for stronger connective tissue Reducing inflammation and oxidative stress Regenerating intestinal lining and restoring gut-brain axis balance Improving blood flow, nitric oxide function, and tissue oxygenation Conditions Supported by BPC-157 Therapy Muscle, Tendon & Ligament Repair Muscle tears, microtears, and overuse injuries Tendonitis (Achilles, patellar, rotator cuff, biceps) Ligament injuries (ACL, MCL, meniscus) Sports injuries and post-surgical recovery Joint & Bone Regeneration Osteoarthritis and degenerative joint pain Cartilage loss and stiffness Bone fractures and delayed healing Post-reconstruction ligament rehabilitation Nerve & Pain Syndromes Peripheral nerve damage Sciatica and neuropathic pain Fibromyalgia and myofascial pain BPC-157 and Gut-Brain Axis Health BPC-157 supports the gut-brain axis the communication link between digestion and mental health by repairing the gut lining and reducing inflammation
This suggests it maintains functional dopamine storage and release mechanisms even when structural components are damaged
Cyanocobalamin is a synthetic form of vitamin B12 thats not found in nature ( Its used more frequently in supplements, as its considered more stable and cost effective than other forms of vitamin B12
[4] The proposed mechanism of action, based only on preclinical animal studies, involves potential modulation of growth factor pathways, particularly vascular endothelial growth factor (VEGF), which may promote angiogenesisthe formation of new blood vessels
doi:10.1111/j.1600-0714.1990.tb00825.x 13
